Cargando…
Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer
Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other canc...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599945/ https://www.ncbi.nlm.nih.gov/pubmed/36291804 http://dx.doi.org/10.3390/cancers14205020 |
| _version_ | 1784816718864973824 |
|---|---|
| author | Chambers, Setsuko K. |
| author_facet | Chambers, Setsuko K. |
| author_sort | Chambers, Setsuko K. |
| collection | PubMed |
| description | Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access. |
| format | Online Article Text |
| id | pubmed-9599945 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95999452022-10-27 Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer Chambers, Setsuko K. Cancers (Basel) Commentary Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access. MDPI 2022-10-14 /pmc/articles/PMC9599945/ /pubmed/36291804 http://dx.doi.org/10.3390/cancers14205020 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Commentary Chambers, Setsuko K. Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title | Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title_full | Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title_fullStr | Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title_full_unstemmed | Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title_short | Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer |
| title_sort | advances in chemotherapy and targeted therapies in endometrial cancer |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599945/ https://www.ncbi.nlm.nih.gov/pubmed/36291804 http://dx.doi.org/10.3390/cancers14205020 |
| work_keys_str_mv | AT chamberssetsukok advancesinchemotherapyandtargetedtherapiesinendometrialcancer |